Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10500)
All Articles published online
|
Publishing Process of This Article
|
Dec 10, 2014 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Chung BM, Tom E, Zutshi N, Bielecki TA, Band V, Band H. Nexus of signaling and endocytosis in oncogenesis driven by non-small cell lung cancer-associated epidermal growth factor receptor mutants. World J Clin Oncol 2014; 5(5): 806-823 [PMID: 25493220 DOI: 10.5306/wjco.v5.i5.806] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v5/i5/806.htm |
| Number | Citing Articles |
| 1 |
Yuki Matsumura, Yuki Owada, Takumi Yamaura, Satoshi Muto, Jun Osugi, Mika Hoshino, Mitsunori Higuchi, Tetsuya Ohira, Hiroyuki Suzuki, Mitsukazu Gotoh. Epidermal growth factor receptor gene mutation as risk factor for recurrence in patients with surgically resected lung adenocarcinoma: a matched-pair analysis. Interactive CardioVascular and Thoracic Surgery 2016; 23(2): 216 doi: 10.1093/icvts/ivw116
|
| 2 |
Larisa Venkova, Alexander Aliper, Maria Suntsova, Roman Kholodenko, Denis Shepelin, Nicolas Borisov, Galina Malakhova, Raif Vasilov, Sergey Roumiantsev, Alex Zhavoronkov, Anton Buzdin. Combinatorial high-throughput experimental and bioinformatic approach identifies molecular pathways linked with the sensitivity to anticancer target drugs. Oncotarget 2015; 6(29): 27227 doi: 10.18632/oncotarget.4507
|
| 3 |
Ping Wee, Zhixiang Wang. Regulation of EGFR Endocytosis by CBL During Mitosis. Cells 2018; 7(12): 257 doi: 10.3390/cells7120257
|
| 4 |
Zifang Zou, Xiaoxi Fan, Yang Liu, Yanbin Sun, Xin Zhang, Guanghao Sun, Xuehao Li, Shun Xu. Endogenous thrombopoietin promotes non‐small‐cell lung carcinoma cell proliferation and migration by regulating EGFR signalling. Journal of Cellular and Molecular Medicine 2020; 24(12): 6644 doi: 10.1111/jcmm.15314
|
| 5 |
Dandan Tong, Ya-Nan Liang, AA Stepanova, Yu Liu, Xiaobo Li, Letian Wang, Fengmin Zhang, NV Vasilyeva. Increased Eps15 homology domain 1 and RAB11FIP3 expression regulate breast cancer progression via promoting epithelial growth factor receptor recycling. Tumor Biology 2017; 39(2): 101042831769101 doi: 10.1177/1010428317691010
|
| 6 |
Eric C. Tom, Insha Mushtaq, Bhopal C. Mohapatra, Haitao Luan, Aaqib M. Bhat, Neha Zutshi, Sukanya Chakraborty, Namista Islam, Priyanka Arya, Timothy A. Bielecki, Fany M. Iseka, Sohinee Bhattacharyya, Luke R. Cypher, Benjamin T. Goetz, Simarjeet K. Negi, Matthew D. Storck, Sandeep Rana, Angelika Barnekow, Pankaj K. Singh, Guoguang Ying, Chittibabu Guda, Amarnath Natarajan, Vimla Band, Hamid Band. EHD1 and RUSC2 Control Basal Epidermal Growth Factor Receptor Cell Surface Expression and Recycling. Molecular and Cellular Biology 2020; 40(7) doi: 10.1128/MCB.00434-19
|
| 7 |
Linyan Wang, Haiyun Wang, Dongli Song, Menglin Xu, Michael Liebmen. New strategies for targeting drug combinations to overcome mutation-driven drug resistance. Seminars in Cancer Biology 2017; 42: 44 doi: 10.1016/j.semcancer.2016.11.002
|
| 8 |
Hisham Saafan, Sarah Foerster, Zinnia P. Parra-Guillen, Elke Hammer, Martin Michaelis, Jindrich Cinatl, Uwe Völker, Holger Fröhlich, Charlotte Kloft, Christoph A. Ritter. Utilising the EGFR interactome to identify mechanisms of drug resistance in non-small cell lung cancer – Proof of concept towards a systems pharmacology approach. European Journal of Pharmaceutical Sciences 2016; 94: 20 doi: 10.1016/j.ejps.2016.04.025
|
| 9 |
In Kim, In Sung, Jae Sim, Minhee Park, Keun-Yeong Jeong, Hwan Kim. Antitumor Effect of Calcium-Mediated Destabilization of Epithelial Growth Factor Receptor on Non-Small Cell Lung Carcinoma. International Journal of Molecular Sciences 2018; 19(4): 1158 doi: 10.3390/ijms19041158
|
| 10 |
Jiaqi Ren, Linlin Lv, Xufeng Tao, Xiaohan Zhai, Xuyang Chen, Hao Yu, Xinya Zhao, Xin Kong, Zhan Yu, Deshi Dong, Jing Liu. The role of CBL family ubiquitin ligases in cancer progression and therapeutic strategies. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1432545
|
| 11 |
Marisa L. Martin-Fernandez. Fluorescence Imaging of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Resistance in Non-Small Cell Lung Cancer. Cancers 2022; 14(3): 686 doi: 10.3390/cancers14030686
|
| 12 |
Qingqing Zhou, Jiajun Li, Chao Ge, Jinsi Chen, Wei Tian, Hua Tian. SNX5 suppresses clear cell renal cell carcinoma progression by inducing CD44 internalization and epithelial-to-mesenchymal transition. Molecular Therapy - Oncolytics 2022; 24: 87 doi: 10.1016/j.omto.2021.12.002
|
| 13 |
Taishu Wang, Jinrui Zhang, Shanshan Wang, Xiuna Sun, Duchuang Wang, Yurou Gao, Yang Zhang, Lu Xu, Yue Wu, Yueguang Wu, Fang Liu, Xiuxiu Liu, Shuyan Liu, Yingqiu Zhang, Yang Wang, Lijuan Zou, Han Liu. The exon 19-deleted EGFR undergoes ubiquitylation-mediated endocytic degradation via dynamin activity-dependent and -independent mechanisms. Cell Communication and Signaling 2018; 16(1) doi: 10.1186/s12964-018-0245-y
|
| 14 |
Sonali Bahl, Hongbo Ling, Nuwan P. N. Acharige, Irene Santos-Barriopedro, Mary Kay H. Pflum, Edward Seto. EGFR phosphorylates HDAC1 to regulate its expression and anti-apoptotic function. Cell Death & Disease 2021; 12(5) doi: 10.1038/s41419-021-03697-6
|
| 15 |
Yu Liu, Yanan Liang, Ming Li, Duanyang Liu, Jing Tang, Weiwei Yang, Dandan Tong, Xiaoming Jin. Eps15 homology domain 1 promotes the evolution of papillary thyroid cancer by regulating endocytotic recycling of epidermal growth factor receptor. Oncology Letters 2018; doi: 10.3892/ol.2018.9200
|
| 16 |
David J. Iberri, A. Dimitrios Colevas. Balancing Safety and Efficacy of Epidermal Growth Factor Receptor Inhibitors in Patients With Squamous Cell Carcinoma of the Head and Neck. The Oncologist 2015; 20(12): 1393 doi: 10.1634/theoncologist.2015-0177
|
| 17 |
Srikumar M. Raja, Swapnil S. Desale, Bhopal Mohapatra, Haitao Luan, Kruti Soni, Jinjin Zhang, Matthew A. Storck, Dan Feng, Timothy A. Bielecki, Vimla Band, Samuel M. Cohen, Tatiana K. Bronich, Hamid Band. Marked enhancement of lysosomal targeting and efficacy of ErbB2-targeted drug delivery by HSP90 inhibition. Oncotarget 2016; 7(9): 10522 doi: 10.18632/oncotarget.7231
|
| 18 |
Bo Mi Ku, Yeon-Hee Bae, Jiae Koh, Jong-Mu Sun, Se-hoon Lee, Jin Seok Ahn, Keunchil Park, Myung-Ju Ahn. AZD9291 overcomes T790 M-mediated resistance through degradation of EGFRL858R/T790M in non-small cell lung cancer cells. Investigational New Drugs 2016; 34(4): 407 doi: 10.1007/s10637-016-0350-y
|
| 19 |
Erin Greenwood, Sabrina Maisel, David Ebertz, Atlantis Russ, Ritu Pandey, Joyce Schroeder. Llgl1 prevents metaplastic survival driven by epidermal growth factor dependent migration. Oncotarget 2016; 7(38): 60776 doi: 10.18632/oncotarget.11320
|
| 20 |
Shaifali Singh, Nai Yang Yeat, Ya-Ting Wang, Shu-Yu Lin, I-Ying Kuo, Kuen-Phon Wu, Won-Jing Wang, Wen-Ching Wang, Wu-Chou Su, Yi-Ching Wang, Ruey-Hwa Chen. PTPN23 ubiquitination by WDR4 suppresses EGFR and c-MET degradation to define a lung cancer therapeutic target. Cell Death & Disease 2023; 14(10) doi: 10.1038/s41419-023-06201-4
|